Virus Filters and Inactivators: The Expanding Viral Clearance Toolkit
The Viral Clearance Market is expected to grow from US$ 566.94 million in 2022 to US$ 1.83 billion by 2028 at a healthy CAGR of 21.6% during the forecast period.
As biopharmaceutical production becomes increasingly intricate, the expanding toolkit of virus filters and inactivators stands as a testament to the industry's commitment to safety and quality. In this dynamic landscape, the fortification of biologic drugs is not just a goal; it's a continuous evolution, ensuring that each dose delivered to patients is a promise of purity and efficacy.